Eagle Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Eagle Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-473,672	Closed	-$48.7M	–	570
2023 Q2	$48.7M	Buy	+473,672	New	+$50M	0.27%	125
2023 Q1	–	Sell	-823,124	Closed	-$93.4M	–	586
2022 Q4	$93.4M	Sell	823,124 -99,882	-11%	-$8.3M	0.57%	59
2022 Q3	$57.1M	Sell	923,006 -408,831	-31%	-$28.6M	0.37%	97
2022 Q2	$106M	Buy	1,331,837 +19,643	+1%	+$1.86M	0.67%	40
2022 Q1	$138M	Sell	1,312,194 -109,121	-8%	-$10.6M	0.71%	38
2021 Q4	$154M	Sell	1,421,315 -95,381	-6%	-$10.4M	0.67%	43
2021 Q3	$166M	Sell	1,516,696 -325,987	-18%	-$33.8M	0.75%	24
2021 Q2	$173M	Sell	1,842,683 -584,637	-24%	-$53.8M	0.74%	24
2021 Q1	$220M	Buy	2,427,320 +187,241	+8%	+$15.8M	0.97%	8
2020 Q4	$169M	Sell	2,240,079 -686,792	-23%	-$51M	0.95%	11
2020 Q3	$229M	Buy	2,926,871 +752,602	+35%	+$51.8M	1.18%	2
2020 Q2	$120M	Buy	2,174,269 +303,708	+16%	+$13M	0.68%	31
2020 Q1	$55.4M	Sell	1,870,561 -16,755	-0.9%	-$567K	0.34%	109
2019 Q4	$68.3M	Sell	1,887,316 -617,886	-25%	-$18.9M	0.33%	115
2019 Q3	$68.2M	Sell	2,505,202 -186,898	-7%	-$4.83M	0.35%	106
2019 Q2	$64.8M	Sell	2,692,100 -5,377	-0.2%	-$136K	0.33%	117
2019 Q1	$71.3M	Sell	2,697,477 -7,439	-0.3%	-$176K	0.38%	103
2018 Q4	$52.9M	Sell	2,704,916 -64,525	-2%	-$1.26M	0.33%	119
2018 Q3	$54.2M	Buy	2,769,441 +366,348	+15%	+$6.97M	0.26%	160
2018 Q2	$39.8M	Buy	+2,403,093	New	+$36.6M	0.21%	175
2016 Q4	–	Sell	-1,463,170	Closed	-$26.5M	–	680
2016 Q3	$26.5M	Buy	+1,463,170	New	+$28.6M	0.18%	172

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eagle Asset Management's HZNP Position: Q3 2023 in Review

Eagle Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 473,672 shares — an estimated $48.7M sold.

Eagle Asset Management first reported a position in HZNP in Q3 2016 and held it in 21 quarters. The position peaked at $229M in Q3 2020. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Eagle Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Eagle Asset Management sold 473,672 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $48.7M.
Eagle Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and held it in 21 quarters.
Eagle Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $229M in Q3 2020.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Eagle Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.